📜 Post with us on Reddit
📝 Create a new article
🏭 Create a company page
🇬🇧 - in English
🇫🇷 - en Français (FR)
🇵🇹 - em Português (PT)
🇩🇪 - auf Deutsch (DE)
🇯🇵 - 日本語で (JA)
Sponsored articles

You can edit almost every page by Creating an account and confirming your email.

NeuroSimplicity, LLC

From EverybodyWiki Bios & Wiki

  • Comment: In accordance with the Wikimedia Foundation's Terms of Use, I disclose that I have been paid by my employer for my contributions to this article. JNeuroSci (talk) 01:01, 22 August 2026 (UTC)


NeuroSimplicity, LLC
Private
ISIN🆔
IndustryLife sciences software, neuroimaging, and medical technology
Founded 📆2016; 10 years ago (2016)
Founder 👔Jared S. Rosenblum
Headquarters 🏙️,
Branchburg, New Jersey[1]
,
United States
Area served 🗺️
Key people
Jared S. Rosenblum (founder and president)[2]
Products 📟 The Imaging Suite
Members
Number of employees
🌐 Websiteneurosimplicity.com
📇 Address
📞 telephone

NeuroSimplicity, LLC is an American life sciences and medical technology company founded in 2016 and headquartered in Branchburg, New Jersey.[1][2] The company develops software for neuroscience research, with a focus on integrating and analyzing large-scale neuroimaging data, preclinical imaging data, and related neuroscience datasets. Its flagship product, The Imaging Suite, is a research platform used in preclinical laboratories to unify multi-modal imaging and omics data. NeuroSimplicity also holds a patent portfolio spanning neuroimaging analysis and medical applications, including surgical navigation.[3][4]

History

Jared S. Rosenblum founded NeuroSimplicity in 2016 as an independent company focused on neuroscience data analysis and medical imaging software.[2] The company's preclinical research tools and neuroimaging methods have been validated in peer-reviewed publications, frequently in collaboration with investigators at the National Institutes of Health (NIH).[5][6][7]

The Imaging Suite

The Imaging Suite is NeuroSimplicity's core product: an on-premises software platform for preclinical research teams working with large neuroscience data volumes, including neuroimaging big data from multiple instruments and experiments.[8][5] The platform is designed to replace fragmented laboratory workflows in which scientists manually move preclinical data between separate analysis tools.

Researchers use The Imaging Suite to integrate, visualize, and compare preclinical imaging data and related neuroscience datasets in a single reproducible environment. Reported research applications include:

  • cranial and neurovascular mapping in situ for vascular connectomics, neurovascular interface studies, and whole-head vascular anatomy in preclinical models[5][9]
  • neuroimmunology and brain-border immunity research, including meningeal immunity, dural lymphatic mapping, and spatial analysis of immune structures in cranial tissues[6][7]
  • regional distribution studies and biomarker mapping across experimental cohorts in a shared three-dimensional reference space[5][9]
  • integration of structural preclinical imaging data with molecular imaging, spatial omics data, and other multi-modal neuroscience data from the same specimen[8][9]

Peer-reviewed protocols describe the platform processing iterative neuroimaging acquisitions, aligning preclinical data to standard brain atlases such as the Allen Brain Atlas, and generating reproducible three-dimensional maps for scientific publication and cross-laboratory comparison.[5][9]

Research validation

NeuroSimplicity first reported a dedicated workflow for studying neurovascular interfaces in Cell Reports Methods, a Cell Press journal, in 2022 in work led by Rosenblum with NIH collaborators.[5] That study presented a non-invasive preclinical workflow for murine cranial vascular mapping and documented analysis with the Neurosimplicity Imaging Suite.[5]

A companion protocol in STAR Protocols (2023), developed with NIH collaborators, provides a step-by-step bench guide for laboratories adopting the same preclinical neuroimaging workflow.[9]

NIH-led studies published in Nature later used related cranial imaging and neuroscience data analysis approaches in neuroimmunology research, including the 2024 identification of dural-associated lymphoid tissues and a 2026 report on dynamic dural venous sinuses and meningeal immunity. Rosenblum contributed micro-CT analysis to those papers under a NeuroSimplicity affiliation.[6][10][7][11] Independent review articles and science journalism have discussed the underlying Nature research.[12][13][14]

NIH adoption

NeuroSimplicity has received sole-source designations from the NIH for automated multi-modal neuroimaging and neuroscience data analysis used in mission-critical intramural research. NIH procurement reviews cited no equivalent commercial platform for unified registration, visualization, and quantification of preclinical imaging data across modalities including micro-CT, confocal microscopy, two-photon imaging, and MRI.[15]

Intellectual property

NeuroSimplicity holds U.S. and international patents and patent applications covering automated processing, registration, segmentation, and visualization of scientific imaging data, including neurovascular mapping workflows for neuroscience research and technologies for medical and surgical navigation.[3][4] Patents assigned to the company are indexed in public databases.[3]

Distribution

NeuroSimplicity partners with Avantor Sciences / VWR, an international distributor of laboratory and life sciences products, for global sales and institutional support of its neuroimaging software.[4]

See also

References

  1. ↑ 1.0 1.1 Monaghan KL, Ghabdan Zanluqui N, Rosenblum JS, et al. (2026). "Highly dynamic dural sinuses support meningeal immunity". Nature. doi:10.1038/s41586-026-10165-8. PMID 41708857 Check |pmid= value (help). NeuroSimplicity, Branchburg, NJ, USA.
  2. ↑ 2.0 2.1 2.2 "Jared Rosenblum (0000-0001-5941-9082) — Employment". ORCID. Retrieved 2026-07-01. NeuroSimplicity LLC: 2016 to present.
  3. ↑ 3.0 3.1 3.2 "Assignee: NeuroSimplicity". Google Patents. Retrieved 2026-07-01.
  4. ↑ 4.0 4.1 4.2 "Our Company". NeuroSimplicity. Retrieved 2026-07-01.
  5. ↑ 5.0 5.1 5.2 5.3 5.4 5.5 5.6 Rosenblum JS, Cappadona AJ, Lookian PP, et al. (2022). "Non-invasive in situ visualization of the murine cranial vasculature". Cell Reports Methods. 2 (4). doi:10.1016/j.crmeth.2021.100151. PMC 8967186 Check |pmc= value (help). PMID 35373177 Check |pmid= value (help). Unknown parameter |article-number= ignored (help)
  6. ↑ 6.0 6.1 6.2 Fitzpatrick Z, Ghabdan Zanluqui N, Rosenblum JS, et al. (2024). "Venous-plexus-associated lymphoid hubs support meningeal humoral immunity". Nature. 628 (8008): 612–619. doi:10.1038/s41586-024-07202-9. PMC 11482273 Check |pmc= value (help). PMID 38509366 Check |pmid= value (help).
  7. ↑ 7.0 7.1 7.2 Monaghan KL, Ghabdan Zanluqui N, Rosenblum JS, et al. (2026). "Highly dynamic dural sinuses support meningeal immunity". Nature. doi:10.1038/s41586-026-10165-8. PMID 41708857 Check |pmid= value (help).
  8. ↑ 8.0 8.1 "The Imaging Suite". NeuroSimplicity. Retrieved 2026-07-01.
  9. ↑ 9.0 9.1 9.2 9.3 9.4 Dang DD, Rosenblum JS, et al. (2023). "Visualization of murine in situ neurovascular interfaces". STAR Protocols. 4 (3). doi:10.1016/j.xpro.2023.102367. PMC 10511866 Check |pmc= value (help). PMID 37339049 Check |pmid= value (help). Unknown parameter |article-number= ignored (help)
  10. ↑ Fitzpatrick Z, Ghabdan Zanluqui N, Rosenblum JS, et al. (2024). "Venous-plexus-associated lymphoid hubs support meningeal humoral immunity". Nature. 628 (8008): 612–619. doi:10.1038/s41586-024-07202-9. PMID 38509366 Check |pmid= value (help). J.S.R. is affiliated with NeuroSimplicity, which is a medical device and technology company focused on medical image processing.
  11. ↑ Monaghan KL, Ghabdan Zanluqui N, Rosenblum JS, et al. (2026). "Highly dynamic dural sinuses support meningeal immunity". Nature. doi:10.1038/s41586-026-10165-8. J.S.R. analysed and generated images from micro-CT data.
  12. ↑ Zhang X, Liu L, Chai Y, et al. (2024). "Reimagining the meninges from a neuroimmune perspective: a boundary, but not peripheral". Journal of Neuroinflammation. 21. doi:10.1186/s12974-024-03286-2. Unknown parameter |article-number= ignored (help)
  13. ↑ Alexander JF, Smyth LC (2024). "DALT: the brain's border patrol". Cell Research. 34 (9): 603–604. doi:10.1038/s41422-024-00976-7. PMC 11369212 Check |pmc= value (help). PMID 38777860 Check |pmid= value (help).
  14. ↑ Jackson J (2026-02-23). "Not just drainage: Dural venous sinuses actively regulate brain immunity and fluid flow, study finds". Medical Xpress. Retrieved 2026-07-01.
  15. ↑ "75N95023Q00030 — Neurosimplicity Data Analysis software". National Institute on Drug Abuse. Retrieved 2026-07-01. Neurosimplicity is the only software able to deformably register, visualize, and quantify imaging data from different sources (microCT, confocal, two-photon, MRI, etc.) in the same 3D space... required for current and future needs of the Viral Immunology and Intravital Imaging Section.

External links


This article "NeuroSimplicity" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:NeuroSimplicity. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.


Retrieved from "https://en.everybodywiki.com/index.php?title=NeuroSimplicity&oldid=6501176"
License CC BY-SA 3.0
Powered by MediaWiki